StockData
OPKO Health, Inc. logo

OPKO Health, Inc. (OPK) stock

OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.69+0.07 (+4.32%)

Close on Nov 18, 2026Market cap $1.26BP/E –Yield –

OPKO Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

OPKO Health's revenue for the twelve months ending Jun 30, 2026 was $587.90M, down 11.5% year over year. For fiscal 2025 it was $606.88M, down 14.9% from the year before. Over ten years it grew 2.1% a year on average. The highest annual figure on record is $1.77B in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$606.88M-14.9%
FY2024Dec 31, 2024$713.14M-17.4%
FY2023Dec 31, 2023$863.50M-14.0%
FY2022Dec 31, 2022$1.00B-43.4%
FY2021Dec 31, 2021$1.77B+23.6%
FY2020Dec 31, 2020$1.44B+59.1%
FY2019Dec 31, 2019$901.94M-8.9%
FY2018Dec 31, 2018$990.27M+2.5%
FY2017Dec 31, 2017$966.01M-13.6%
FY2016Dec 31, 2016$1.12B+127.3%
FY2015Dec 31, 2015$491.74M+439.6%
FY2014Dec 31, 2014$91.13M-5.6%
FY2013Dec 31, 2013$96.53M+105.2%
FY2012Dec 31, 2012$47.04M+68.1%
FY2011Dec 31, 2011$27.98M-1.8%
FY2010Dec 31, 2010$28.49M+545.0%
FY2009Dec 31, 2009$4.42M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$163.58M+4.3%
Q1 FY2026Mar 31, 2026$124.20M-17.2%
Q4 FY2025Dec 31, 2025$148.45M-19.2%
Q3 FY2025Sep 30, 2025$151.67M-12.6%
Q2 FY2025Jun 30, 2025$156.81M-13.9%
Q1 FY2025Mar 31, 2025$149.95M-13.7%
Q4 FY2024Dec 31, 2024$183.64M+1.0%
Q3 FY2024Sep 30, 2024$173.63M-2.8%
Q2 FY2024Jun 30, 2024$182.19M-31.4%
Q1 FY2024Mar 31, 2024$173.69M-26.9%
Q4 FY2023Dec 31, 2023$181.91M-1.9%
Q3 FY2023Sep 30, 2023$178.60M-0.6%
Q2 FY2023Jun 30, 2023$265.42M-14.4%
Q1 FY2023Mar 31, 2023$237.58M-27.8%
Q4 FY2022Dec 31, 2022$185.34M-53.8%
Q3 FY2022Sep 30, 2022$179.74M-53.4%
Q2 FY2022Jun 30, 2022$309.89M-30.0%
Q1 FY2022Mar 31, 2022$329.22M-39.6%
Q4 FY2021Dec 31, 2021$401.33M-18.9%
Q3 FY2021Sep 30, 2021$385.81M-9.9%
Q2 FY2021Jun 30, 2021$442.41M+46.9%
Q1 FY2021Mar 31, 2021$545.17M+157.8%
Q4 FY2020Dec 31, 2020$494.68M+120.5%
Q3 FY2020Sep 30, 2020$428.06M+87.1%
Q2 FY2020Jun 30, 2020$301.21M+33.1%
Q1 FY2020Mar 31, 2020$211.47M-4.9%
Q4 FY2019Dec 31, 2019$224.34M+1.1%
Q3 FY2019Sep 30, 2019$228.77M-8.4%
Q2 FY2019Jun 30, 2019$226.37M-14.2%
Q1 FY2019Mar 31, 2019$222.45M-12.7%
Q4 FY2018Dec 31, 2018$221.85M+37.8%
Q3 FY2018Sep 30, 2018$249.82M+1.5%
Q2 FY2018Jun 30, 2018$263.69M-9.9%
Q1 FY2018Mar 31, 2018$254.91M-4.3%
Q4 FY2017Dec 31, 2017$160.98M-41.6%
Q3 FY2017Sep 30, 2017$246.04M-17.4%
Q2 FY2017Jun 30, 2017$292.60M–
Q1 FY2017Mar 31, 2017$266.38M–
Q4 FY2016Dec 31, 2016$275.49M–
Q3 FY2016Sep 30, 2016$298.04M–

More OPKO Health figures

See a number that looks wrong?